1-3 of 3
Oliver Leismann, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Deferasirox in Patients with Transfusional Iron Overload After Allogeneic Hematopoietic Cell Transplantation: The CICL670ADE02 Trial

Haifa Kathrin Al-Ali, MD, Nadja Jaekel, MD, Kai Lieder, Dr., Stefan Albrecht, PhD, Oliver Leismann, PhD, Karolin Hubert, Mrs, Gesine Bug, Nicolaus Kroeger, MD, Uwe Platzbecker, MD, Michael Stadler, MD, Katherina de Haas, MD, Dietger Niederwieser
Journal: Blood
Blood (2012) 120 (21): 485.
https://doi.org/10.1182/blood.V120.21.485.485
Published: 2012
Journal Articles

Effective and Safe Deferasirox Treatment of Patients with Various anemia's and Transfusional Iron-Overload in the Medical Practice: Results From Two German Observational Studies

Christian Junghanss, MD, Rudolf Schlag, MD, Bernd Gaede, MD, Matthias Moelle, MD, Steffen Doerfel, Frank Heits, MD, Ulrike Haus, PhD, Alexia Junkes, PhD, Oliver Leismann, PhD
Journal: Blood
Blood (2011) 118 (21): 5165.
https://doi.org/10.1182/blood.V118.21.5165.5165
Published: 2011
Journal Articles

Intraindividual Comparison between Deferasirox and Deferoxamine in Thalassemia.

Roland Fischer, PhD, Regine Grosse, Rainer Engelhardt, PhD, Peter Nielsen, PhD, MD, Oliver Leismann, PhD, Gritta E. Janka, MD
Journal: Blood
Blood (2007) 110 (11): 2776.
https://doi.org/10.1182/blood.V110.11.2776.2776
Published: 2007